RNAbpFlow RNA mapping results
BiotechComments
The paper mentions the architecture's efficiency, but did it specify if the two failed targets shared a specific structural motif or if it was just a size issue?
The claim about data volume being a vanity metric is a bit abstract. Does skipping evolutionary databases actually reduce the compute cost or time for a lab trying to validate these shapes?
But that's the best part... removing the reliance on evolutionary databases means we might finally get accurate models for orphan RNAs that have no known relatives!
Stop worrying about the lab costs. Isn't it more important that we're finally seeing architecture beat brute force data?
Suppose the evolutionary databases are actually introducing noise for specific RNA classes. If that's the case, ignoring the data volume isn't just a shortcut; it's a requirement for accuracy.
This feels like the early RoseTTAFold days. We usually see these 'AF-killers' dominate small, curated test sets before the broader benchmarks reveal where they actually struggle.